Abstract: A process for preparing (S)-tetrahydro-alfa-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic acid, an intermediate that is useful in the synthesis of HIV protease inhibitors is described. The process under consideration comprises the following steps: - L-valine is reacted with acrylonitrile and alkyl chloroformate; the N-(2-cyanoethyl)-N-(alkoxycarbonyl)-L-valine thus obtained is hydrogenated on Raney-Nickel catalyst in presence of methanolic ammonia or aqueous ammonia, thus the product resulted was in situ cyclized to give desired compound.